General Information of the Compound
Compound ID |
CP0959433
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
SID50106961
Show/Hide
|
||||||||||||||||||
Synonyms |
(R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol hydrochloride
(R)-3-[2-[2-(4-Methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride
261901-57-9
ANW-62575
BCP14529
C18H29ClN2O3S
CHEMBL1256844
CTK8B9470
EU-0101059
KS-00000XMZ
MFCD03788020
MLS002153418
MolPort-003-959-592
SB 269970 hcl
SB 269970 hydrochloride
SB 269970-A
SB-269970 (hydrochloride)
SB-269970 HCl
SB-269970 hydrochloride
SB269970 HCl
SB269970 hydrochloride
SCHEMBL2719586
SR-01000076135
Tox21_501059
s2849
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H29ClN2O3S
|
||||||||||||||||||
Molecular Weight |
388.961
|
||||||||||||||||||
Canonical SMILES |
CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1.Cl
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H28N2O3S.ClH/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18;/h2,5-6,14-16,21H,3-4,7-13H2,1H3;1H/t16-;/m1./s1
Show/Hide
|
||||||||||||||||||
InChIKey |
XQCJOYZLWFNDIO-PKLMIRHRSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound